An agreement has been reached with the counterparty Curexa in the legal dispute that QleanAir's US subsidiary has been pursuing since the autumn of 2024. The settlement means that neither party has any further claims on each other. The assessment is that the financial effect of this settlement will have a limited positive effect on cash flow and a positive effect on earnings in the first quarter of 2026 of approximately SEK 6 million, which mainly consists of a release of a previously made provision.